Sangart

Sangart is a biotechnology company focused on developing innovative therapies for blood-related conditions and oxygen delivery. Its main product, a synthetic hemoglobin, aims to improve oxygen transport in the body, which can be beneficial in medical situations like surgery or trauma. By creating a safe and effective alternative to donor blood, Sangart's work has the potential to address shortages in blood supplies and enhance patient outcomes during critical health events. The company's research and technology contribute to advancements in medicine and patient care.